Robert K. Jenner

Jenner Law
1829 Reisterstown Rd Ste 350
Pikesville, MD 21208
(410) 413-2155
www.jennerlawfirm.com


As the former head of the Mass Tort Division at Janet, Jenner & Suggs, LLC (JJS), Rob Jenner has repeatedly been selected by federal and state courts to lead teams of attorneys against some of the nation's most powerful drug and device companies.

Among the many accolades Rob Jenner has received over his 33 years' experience, he has been consistently recognized by Best Lawyers since 2005. Jenner has been named Lawyer of the Year (2013, 2016) and, in 2017, was named as one of America's 50 Most Influential Trial Lawyers by the National Trial Lawyers. JJS was also named as one of the Best Law Firms in America for Mass Torts due to the winning results of Rob's team.

Robert K. Jenner brings more than 33 years experience representing injured consumers nationwide against the manufacturers of dangerous prescription drugs, defective medical devices and tainted blood products. Rob has assembled a team of attorneys, paralegals and health care professionals dedicated to prosecuting claims on behalf of injured consumers.

Rob has been honored by Best Lawyers every year since 2006 and was in both 2013 and 2016 was named Baltimore Mass Tort Litigation/Class Actions - Plaintiffs "Lawyer of the Year." He is also routinely honored in the Top 100 lawyers in Maryland's "Super Lawyers."

Rob is currently court-appointed Co-Lead Counsel of the Massachusetts consolidation of 7,000+ Granuflo state cases; and co-lead counsel of the Skechers Toning Shoes litigation (MDL). He is also court appointed Liaison Counsel for both the Zofran litigation (MDL) in Boston, and the Smith & Nephew BHR hip implant litigation (MDL) in Baltimore.

A Past President of the Maryland Trial Lawyers Association (currently the Maryland Association for Justice, MAJ), Rob now sits on MAJs Executive Committee. In May 2009, MAJ Awarded he and his co-counsel its Trial Lawyer of the Year Award for their efforts in challenging the illegal subrogation practices of Maryland's HMOs.

A significant portion of his commitment to the civil justice system is evidenced by Rob's participation in the American Association for Justice (AAJ). He is Chair of AAJ's Publications Committee, which oversees the publication of TRIAL magazine, the nation's largest and most reputable magazine for trial lawyers. He is also a past Chair of AAJ's Section on Toxic, Environmental and Pharmaceutical Torts. Rob currently serves as Co-Chair of AAJ's Zofran Litigation Group. In addition, he has formerly served as Chair of the Pain Pump-Chondrolysis Litigation Group; Vice-Chair of the Hormone Therapy Litigation Group; Rezulin Litigation Group; Baycol Litigation Group; AIDS Litigation Group; Latex Toxicity Litigation Group; and HMO Litigation Group. In July 2002, 2003, 2004 and 2008, AAJ awarded him its Wiedemann-Wysocki Medal for his commitment to AAJ and the civil justice system.

He has written more than 25 articles published in nationally recognized legal and health care journals. In addition, he is the author of the legal treatise on representing the victims of HIV acquired from defective blood products, Transfusion - Associated AIDS (Lawyers & Judges Publishing Co., 1995).

Rob is also a frequent lecturer, having been invited to speak on medical/legal issues both nationally and internationally. He has organized and moderated dozens of acclaimed seminars in conjunction with AAJ's National College of Advocacy on the issues of Zofran, Pradaxa, Vioxx, Hormone Therapy, Baycol, Rezulin, and general pharmaceutical and mass tort litigation.

Rob is a member of the bars of Maryland, Massachusetts, and the District of Columbia. He was honored by his peers by being inducted into the International Society of Barristers, one of the country's most selective attorney honorary societies. He has obtained the highest rating (AV) by his peers as reflected in Martindale-Hubbell.

Rob is a volunteer for Lab Rescue of the LRCP, as well as an avid scuba diver who is always willing to take suggestions for great dive destinations.